New registered manufacturer is publicly announced

in page functions

With the June launch of the pilot AMC against pneumococcal disease, manufacturers are now registering to participate

Geneva, 30 September 2009 - Panacea Biotect Ltd and the Serum institute of India are two of the companies that have begun the registration process in order to participate. Several companies have inquired about the pilot.

Information about the number and names of manufacturers is confidential unless a firm requests its information to be made public.

For more information about the AMC registration process please contact: amc@gavi.org 

22 million

Since 2007, countries have immunised 22 million children with a 2nd dose of measles vaccine with Gavi support. Gavi-funded measles campaigns have helped vaccinate another 67 million children in countries considered at high risk of measles outbreaks.

WHO/UNICEF 2015

More facts...

close icon

modal window here